Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy

Table 5 Comparison of serum alpha-fetoprotein levels in different stages (mean ± SD)

Group	AFP (μg/L)
	1 mo after the operation	3 mo after the operation	6 mo after the operation	1 year after the operation
TACE group (n = 119)	38.33 ± 4.78	38.67 ± 5.32	36.45 ± 3.24	31.53 ± 3.54
TACE + TARE group (n = 99)	36.45 ± 5.68	35.53 ± 4.45	32.37 ± 3.47	28.78 ± 3.25
χ2	2.654	4.669	8.963	5.926
P value	0.009	< 0.001	< 0.001	< 0.001

AFP: Alpha-fetoprotein; TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization.